NLM Logo

Ado-Trastuzumab Emtansine MeSH Descriptor Data 2022


MeSH Heading
Ado-Trastuzumab Emtansine
Tree Number(s)
D02.540.505.495.500
D04.345.295.500.500
D12.776.124.486.485.114.224.060.875.500
D12.776.124.790.651.114.224.060.875.500
D12.776.377.715.548.114.224.200.875.500
Unique ID
D000080044
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000080044
Scope Note
Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.
Entry Term(s)
Kadcyla
Trastuzumab Emtansine
Trastuzumab-DM1
Trastuzumab-DM1 Conjugate
huN901-DM1
Pharm Action
Antineoplastic Agents, Immunological
Immunotoxins
Tubulin Modulators
Registry Number
SE2KH7T06F
Public MeSH Note
2020; ADO-TRASTUZUMAB EMTANSINE was indexed under TRASTUZUMAB and MAYTANSINE 2012-2019 and under ANTIBODIES, MONOCLONAL 2010-2011
History Note
2020 (2010)
Date Established
2020/01/01
Date of Entry
2019/07/08
Revision Date
2019/01/16
Ado-Trastuzumab Emtansine Preferred
Kadcyla Narrower
huN901-DM1 Narrower
Trastuzumab-DM1 Conjugate Narrower
page delivered in 0.142s